Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke
about
Current status of biomarker research in neurologyRole of Homocysteine in the Ischemic Stroke and Development of Ischemic ToleranceNeuroprotective Strategies during Cardiac Surgery with Cardiopulmonary BypassUpdate on Inflammatory Biomarkers and Treatments in Ischemic StrokeC1q/Tumor Necrosis Factor-Related Protein-3 Attenuates Brain Injury after Intracerebral Hemorrhage via AMPK-Dependent Pathway in RatAnti-inflammatory and anti-excitoxic effects of diethyl oxopropanamide, an ethyl pyruvate bioisoster, exert robust neuroprotective effects in the postischemic brain.The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9.The High Cost of Stroke and Stroke Cytoprotection Research.Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.Potential biomarkers for predicting hemorrhagic transformation of ischemic stroke.Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke.The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.Key Aging-Associated Alterations in Primary Microglia Response to Beta-Amyloid Stimulation.Neutrophil polarization by IL-27 as a therapeutic target for intracerebral hemorrhageEarly administration of pyrrolidine dithiocarbamate extends the therapeutic time window of tissue plasminogen activator in a male rat model of embolic stroke.Impact of neonatal hypoxia-ischaemia on oligodendrocyte survival, maturation and myelinating potential.Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis.Exposure to traffic-generated air pollutants mediates alterations in brain microvascular integrity in wildtype mice on a high-fat diet.Selective knockout of astrocytic Na+ /H+ exchanger isoform 1 reduces astrogliosis, BBB damage, infarction, and improves neurological function after ischemic stroke.The role of the lectin-like oxLDL receptor (LOX-1) in traffic-generated air pollution exposure-mediated alteration of the brain microvasculature in Apolipoprotein (Apo) E knockout mice.Hepatic acute phase response protects the brain from focal inflammation during postnatal window of susceptibility.Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.Blood-brain barrier dysfunction and recovery after ischemic stroke.Fibrinolysis: from blood to the brain.β-Caryophyllene protects in vitro neurovascular unit against oxygen-glucose deprivation and re-oxygenation-induced injury.Regulation function of MMP-1 downregulated by siRNA on migration of heat-denatured dermal fibroblasts.Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke.Critical Care Management of Acute Ischemic Stroke.Increase of Meningitis Risk in Stroke Patients in Taiwan.Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.Networks of blood proteins in the neuroimmunology of schizophrenia.Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice.Characterization of the rat cerebrospinal fluid proteome following acute cerebral ischemia using an aptamer-based proteomic technology.SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.Reperfusion Injury after ischemic Stroke Study (RISKS): single-centre (Florence, Italy), prospective observational protocol study.Carbon monoxide-releasing molecule-3 protects against ischemic stroke by suppressing neuroinflammation and alleviating blood-brain barrier disruption.Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeabilityRegenerative Medicine Therapies for Targeting Neuroinflammation After Stroke
P2860
Q26744505-2C5115B6-8940-4033-A782-7CF20964718AQ28073469-1E7E7304-9089-48F6-B880-B7AA057178B4Q28076954-605AC749-3B13-406D-9795-894644E3F8B9Q28078744-D891A78B-C14D-4BC4-9553-6655B8C2E7A3Q37348664-4871E750-FD75-4F28-8DD8-ED40B6ADB22DQ37654867-4F83002D-66AE-4C9E-8AFC-8C41D96378CCQ38639528-55F38D42-3604-47FF-8C50-B5EC0F66F024Q38776049-3B6CC44D-49AD-4560-AD7E-2BF3FC2F9754Q39008879-F40029A5-9E72-4AF3-84A4-676272717C57Q39447215-D51C217A-7366-4673-A8CF-702A55EB0AB6Q41314097-59958205-4ACD-4AE7-BEA4-5DB7C513D9EFQ41574379-BE025D7D-B893-4176-9FA2-44C771962B26Q41605528-EC12BC4A-9598-409C-86BE-B37A29B90835Q41701180-18575A6D-9A42-456C-AAF5-75C7A0355131Q45069221-BD2E1583-A6CB-43CA-9376-FF9C7BA75CDAQ47126634-672FABC2-F2A1-44B2-92D6-132579E6BBDCQ47132518-FF7FD1B2-9101-4E5C-90AB-A486FBF3C197Q47407286-09B6C9FA-8D53-4C20-840C-117B4EC48B4EQ47765350-DB134D52-582F-4C81-BF59-5DEC8D3CA877Q47785324-076EA78B-0A4D-4984-B4CB-48021EDF5A73Q47848259-D1317455-5B06-44AB-A074-A6DE74B58FC8Q47851530-3CC8A02E-98AD-48CD-A46A-8F9873D1D5E0Q47886411-555641A2-31FF-4864-BCEE-BE1E7467F49BQ47910464-6A98DA32-85D4-42EA-B472-357B53A664F8Q48106697-9DA61D52-B8B8-4C17-B682-A604D652A9F8Q48549173-3C1B3FFE-F437-4B4A-9A3E-2BC9D27179BDQ50206277-46029582-BDD6-4921-910E-282AE27A1F5FQ51741486-829029B3-722F-411C-8C6D-02F6D6974CC2Q52096569-E49AAA02-74A8-4088-B237-7F9ED1760E1DQ52649848-375263DA-EA13-49BA-9DDB-C6288829B81FQ52689036-C7585393-C21F-465C-9A01-58D8CDB23E73Q54944546-76A86876-90B7-462B-A194-5CEFCD490B87Q54979810-1C08E0FB-AC7A-4BAA-8B0F-96B9DEAEF0E3Q55072424-6B6851C4-086F-4276-8CB2-F03CAC8F81B2Q55116313-1E808715-3F95-4FA0-93DD-4D25B8019B10Q55194092-3BCAFEEC-1602-4ACC-942B-3C9934EC81BAQ55311462-66BFD774-4214-40CB-9E66-E02FC7B57339Q55452849-2E3C7F2D-F3F2-467B-9247-58687F471156Q56481034-BCDD7D81-E311-4464-AFB3-1E59104A1135Q57161682-33A61D2C-B63F-4349-A425-A656250FF4ED
P2860
Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Implications of MMP9 for Blood ...... tion Following Ischemic Stroke
@ast
Implications of MMP9 for Blood ...... tion Following Ischemic Stroke
@en
Implications of MMP9 for Blood ...... tion Following Ischemic Stroke
@nl
type
label
Implications of MMP9 for Blood ...... tion Following Ischemic Stroke
@ast
Implications of MMP9 for Blood ...... tion Following Ischemic Stroke
@en
Implications of MMP9 for Blood ...... tion Following Ischemic Stroke
@nl
prefLabel
Implications of MMP9 for Blood ...... tion Following Ischemic Stroke
@ast
Implications of MMP9 for Blood ...... tion Following Ischemic Stroke
@en
Implications of MMP9 for Blood ...... tion Following Ischemic Stroke
@nl
P2860
P3181
P356
P1476
Implications of MMP9 for Blood ...... tion Following Ischemic Stroke
@en
P2093
Frank R Sharp
Renée J Turner
P2860
P3181
P356
10.3389/FNCEL.2016.00056
P407
P577
2016-01-01T00:00:00Z